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Available online 25 November 2014Abstract The CD71/Ter119 combination has been widely used to reflect dynamic maturation of erythrocytes in vivo.
However, because CD71 is expressed on all proliferating cells, it is unclear whether it can be utilized as an erythrocyte-specific
marker during differentiation of embryonic stem cells (ESCs). In this study, we revealed that a population expressing high level
of CD71 (CD71high) during mouse ESC differentiation represented an in vitro counterpart of yolk sac-derived primitive
erythroblasts (EryPs) isolated at 8.5 days post coitum. In addition, these CD71high cells went through “maturational globin
switching” and enucleated during terminal differentiation in vitro that were similar to the yolk sac-derived EryPs in vivo. We
further demonstrated that the formation of CD71high population was regulated differentially by key factors including Scl,
HoxB4, Eaf1, and Klf1. Taken together, our study provides a technical advance that allows efficient segregation of EryPs from
differentiated ESCs in vitro for further understanding molecular regulation during primitive erythropoiesis.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Mammalian hematopoiesis is a dynamic process that is
regulated spatially and temporarily through embryonic devel-
opment (Baron and Fraser, 2005; Godin andCumano, 2002; Palis
et al., 1995). In mouse embryos, the initial wave of primitive
hematopoiesis occurs around 7.5 days post coitum (dpc) at
extraembryonic yolk sac (YS) and is characterized by large
nucleated erythrocytes, megakaryocytes, and macrophages⁎ Corresponding author at: Shanghai Key Laboratory of Regulatory
Biology, Institute of Biomedical Sciences and School of Life Sciences,
East China Normal University, 500 Dongchuan Road, Shanghai
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).(Baron and Fraser, 2005; Godin and Cumano, 2002; Palis et
al., 1995). The successive wave of definitive hematopoiesis can
be detected in extraembryonic YS as well and in the intra-
embryonic aorta-gonad-mesonephros region at later time point
around 9.5 dpc (Baron and Fraser, 2005; Godin and Cumano,
2002 Palis et al., 1995). The second wave of hematopoiesis
produces multi-lineage blood progenitors including definitive
erythroid and lymphomyeloid lineages that are relocated to
fetal liver (FL) before birth and finally to postnatal bonemarrow
(BM) (Baron and Fraser, 2005; Godin and Cumano, 2002 Palis et
al., 1995).
The primitive erythroblasts (EryPs) generated from the
initial hematopoiesis are the first blood lineage that differen-
tiates and circulates within the embryos (Palis, 2008). They play
critical roles in the transport of oxygen and carbon dioxideis an open access article under the CC BY-NC-ND license
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eling. EryPs distinguish from definitive erythroblasts (EryDs) in
their larger size, unique globin expression, and oxygen carrying
capacity (Baron et al., 2012; Fraser, 2013; Palis et al., 2010). In
addition, although both lineages share a number of common
regulators such as GATA1 and Klf1, recent transcriptome
analyses have demonstrated that several transcriptional regu-
lators are expressed at much higher levels in EryPs than those in
EryDs, including Pbx1, Foxh1, Arid3a, Pdlim7, and Cited2 (Isern
et al., 2011; Kingsley et al., 2013). By contrast, a number of
genes (including Sox6, Nr3c1, Cebpa, Myb, and Irf9) are highly
enriched only in the EryDs from the FL and BM (Isern et al.,
2011; Kingsley et al., 2013). The most dramatic change in
terminal maturation of erythrocytes is enucleation. It was
previously believed that circulating EryPs retained their nuclei,
whereas EryDs enucleated in the FL or in adult BM, before
entering the bloodstream. However, recent studies on mouse
embryos and human embryonic stem cells (ESCs) have revealed
that EryPs also enucleate and undergo progressive maturation
similarly to EryDs (Fraser et al., 2007; Kingsley et al., 2006;
Kingsley et al., 2004; Malik et al., 2013; McGrath et al., 2008).
Although EryPs are essential for embryonic survival, studies
on their development and maturation in vivo are limited by the
restricted numbers of EryPs and the technical difficulties to
access them at early embryonic stages. ESCs have the potential
to proliferate unlimitedly and to differentiate into various types
of hematopoietic cells in vitro (Kyba et al., 2002; Wang et al.,
2005). It has been demonstrated that Flk1+ hemangioblasts
with bi-potential to differentiate into endothelial and hemato-
poietic lineages are precursors of EryPs (Choi et al., 1998). The
CD71/Ter119 combination has been widely used, and its
differential expression pattern correlates well with the matu-
ration stages during development of both EryPs and EryDs in vivo
(Fraser et al., 2007; Zhang et al., 2003). Although Ter119 is
associated with glycophorin A and specifically marks maturing
erythrocytes, CD71 is a transferrin receptor that is widely
expressed on proliferating cells (Levy et al., 1999). It was
reported that almost all embryoid bodies (EBs) differentiated
from mouse ESCs (mESCs) expressed CD71 (Carotta et al.,
2004), therefore it is unclear whether CD71 can be used as an
erythrocyte-specific marker during ESC differentiation.
In this study, we found that CD71 was expressed on all
ESC-derived cells at different levels, nevertheless, EryPs were
highly enriched in the CD71high subpopulation. In addition,
these CD71high cells went through “maturational globin
switching” and enucleated when cultured in vitro. We further
demonstrated that several core hematopoietic transcription
factors differentially regulated the development of CD71high
population from mESCs. We here proposed a technical
advance to segregate EryPs from surrounding cells for further
analysis of the molecular mechanisms regulating the forma-
tion and maturation of erythrocytes.Methods and materials
Cell culture and ESC differentiation
Mouse ESCs were cultured on irradiated MEFs as previously
described (Wang et al., 2013). For EB formation, dissociated
ESCs were plated to allow MEFs to adhere in IMDM/15% FBS
(Invitrogen) with 0.2 mg/ml iron-saturated transferrin(Calbiochem), 4.5 mM α-monothiolglycerol (MTG, Sigma),
and 50 μg/ml ascorbic acid (Sigma). Non-adherent cells
were seeded in hanging drops at 500 cells per 15 μl drop. EBs
were collected at day 2 into slowly rotating petri dishes. To
induce specific gene expression, doxycycline (Dox) was
added to the medium starting from day 2 at 1 μg/ml. Cells
were harvested by collagenase treatment for analyses. MEL
were cultured in RPMI-1640/10% FBS (Invitrogen). Detailed
protocols to establish gene expressing or knockdown con-
structs and Dox-inducible ESC lines were described in
Supplementary information.In vitro erythroid differentiation and mouse tissue
collection
Sorted cells were seeded onto fibronectin-coated plates
(BD Biosciences) in IMDM/15% FBS, 1% detoxified BSA
(Invitrogen), 0.2 mg/ml transferrin, 10 μg/ml human insulin
(Roche), 0.1 mM MTG, and 2 U/ml human EPO (R&D). For
OP9 co-culture, 104 OP9 cells per well were seeded onto
12-well plates overnight, followed by 5 × 105 sorted cells the
next day in IMDM/20 ng/ml SCF/50 U/ml IL-3 (Peprotech),
10 ng/ml human insulin, 1 mg/ml transferrin, and 10 U/ml
human EPO. For macrophages co-culture, adherent cells
from BM in IMDM/10% FBS and M-CSF for 5 days, then
co-cultured with sorted CD71high cells in IMDM/15% knockout
serum (Invitrogen), 10% protein free hybridoma II medium
(Invitrogen), 0.15 mM MTG, and 2 U/mL erythropoietin for
another 4–6 days. C57BL/6 mice were used for tissue
collection and the age of embryos was defined as 0.5 dpc
at noon on the day of vaginal plug observation. All animal
experimental procedures were conducted in accordance
with the local Animal Welfare Act and Public Health Service
Policy.Methylcellulose colony formation
1 × 104 sorted cells were mixed with 1.5 ml of MethoCult
M3434 (Stem cell Technologies) following the manufacture's
instruction. EryP and myeloid-macrophage colonies were
counted respectively at day 5 and day 10 post plating.Flow cytometry analysis and cell sorting
All antibodies used in this study were purchased as
fluorochrome-coupled forms from BD Biosciences. Flow cytom-
etry was performed with FACSCalibur (BD Biosciences) or with
FACSAria II (BD Biosciences). DNA staining of live cells was
performed with Vybrant DyeCycle™ Ruby (Invitrogen) according
to the manufacture's protocol.RT-PCR and quantitative PCR
Total RNAs were extracted with Trizol (Invitrogen) and
cDNAs were synthesized using a PrimeScript® RT reagent Kit
(TaKaRa Biotechnology Co., Ltd.). Real-time PCR was
performed on a Stratagene MX3000P instrument and ana-
lyzed as described previously (Wang et al., 2013). Primers
are listed in Supplementary Table S1.
32 R. Chao et al.Statistical analysis
All real-time PCR data were presented as the average of 4–6
replicates ± one s.e.m. from 2–3 independent experiments.
For all other experiments, one representative experiment
with biological duplicates was shown and results were
reproducible for more than three times. p values were
calculated using GraphPrism software for comparisons, *:
p b 0.05; **: p b 0.01.Results
A distinctive CD71high population exists during
differentiation of mESCs
To investigate if CD71 can be utilized as a marker for
erythroblasts derived from mESCs, we monitored the
percentage of CD71+ cells upon mESC differentiation by
flow cytometry. CD71 appeared to be expressed at all EB
cells differentiated from mESCs (Fig. 1A), consistent with its
function as a proliferation marker as previously reported
(Carotta et al., 2004). In addition, muscle cells were largely
negative for CD71 (the few positive cells likely from
contamination of blood cells in muscles), while distinctive
CD71− and CD71+ populations were seen in BM as well
(Fig. 1A). This suggests that the positivity of CD71 on all EB
cells was not due to artificial draft caused by non-specific
staining. More interestingly, we discovered that a CD71high
population existed along EB differentiation and peaked
around day 5 (Fig. 1B). Only a small fraction of CD31+ or
Flk1+ cells, were co-stained with CD71 around day 4 of EB
differentiation (Fig. 1C), indicating that the segregation of
CD71high population from Flk1+ or CD31+ endothelial cells
has already occurred at that time. At day 4 or day 6, we
observed that a subpopulation of CD71high cells was also
positive for CD41 or c-Kit, markers of known primitive
hematopoietic progenitors, but these cells were clearly
CD45- and Ter119- (Fig. 1C). At day 8 of EB differentiation,
double positive cells for CD71 and Ter119 emerged,
indicating that some CD71high cells matured into Ter119+
erythrocytes (Fig. 1C). These data distinguished the CD71high
population from CD31+ or Flk1+ endothelial cells and from
CD45+ lymphoid–myeloid precursors as well, and thus
proved the existence of CD71high cells as potential erythroid
progenitors.
CD71high marks the primitive erythroblasts
from mESCs
CD71 is expressed at high levels on several types of cells
including erythroblasts and neurons (Levy et al., 1999). To
define the property of CD71high population, we sorted
CD71low (low level of CD71), CD71med (mediate level of
CD71), and CD71high cells from day 5 EBs by flow cytometry
(Supplementary Fig. S1A) and compared the expression
levels of genes that were specific for erythrocyte develop-
ment, megakaryopoiesis, and neuronal development. Com-
pared to CD71low and CD71med cells, CD71high cells expressed
markedly higher levels of Klf1 (the key factor in erythroid
formation) and βH1 (the embryonic hemoglobin) (Fig. 2A). Incontrast, transcript levels of genes for endothelial growth
(Flk1 and Tie2), megakaryopoiesis (Erg and Fli1), and
neuronal development (Ttn and Lmx1b) were significantly
lower (Fig. 2A). To further determine if CD71high cells
represent EryPs, genes to be differentially expressed in
EryPs and EryDs were examined. Notably, we found that
genes reported to express at higher levels in EryP (such as
Pbx1, Foxh1, and Cited2) were enriched in CD71high
populations and YS at 8.5 dpc (Fig. 2B). In contrast, genes
defining EryD identity (such as Sox6 and Cepba) were
expressed at a much lower level in CD71high cells than in
CD71low/med fractions and FL at 14.5 dpc (Fig. 2B). In
addition, similarly to EryPs from YS at 8.5 dpc, βH1
embryonic hemoglobin was the dominant type of globin in
CD71high cells, in contrast to the EryDs from FL and adult BM,
which expressed dramatically high levels of adult type globin
β1 (Fig. 2C). Taken together, these data suggest that the
CD71high population from differentiated mESCs represents an
in vitro counterpart of EryPs from YS at 8.5 dpc in vivo.
To further characterize the CD71high population, sorted
cells were subjected to Wright–Giemsa staining. We found
that the CD71high population consisted of cells with uniform
size and single nuclei, while CD71low/med fraction appeared
to be more heterogeneous (Fig. 2D). We next determined
their hematopoietic potential by colony forming assay. In
this assay, about 800 red colonies per 10,000 CD71high cells
appeared around day 5 post plating and displayed the same
morphology as erythroblast colonies from YS at 8.5 dpc. By
contrast, few erythroblast colonies were detected in
CD71low/med cells (Figs. 2E & F). We only found 16 colonies
that mainly consisted of granulocytes and macrophages from
CD71high cells and 3 in CD71low/med groups. Cells collected
from these EryP colonies displayed similar size and morphol-
ogy as YS-derived erythroid progenitors, in that their nuclei
became smaller after maturing in MethoCult for 5 days
(Fig. 2G). Taken together, our results suggest that the
erythropoietic potential was largely restricted to the
CD71high population from day 5 EBs.Hemoglobin switching and enucleation of CD71high
cells during maturation
As development proceeds, EryPs in vivo continue to mature
in the bloodstream and “maturational globin switching”
occurs from dominant βH1 at 8.5 dpc to comparable levels of
βH1 and εy globins (Kingsley et al., 2006). We examined if
CD71high cells could mature in vitro. After growing in vitro
for two days, CD71low/med cells attached to the bottom of
plates, whereas fractioned CD71high cells existed in suspen-
sion (Fig. 3A). More importantly, although levels of all
globins increased, the εy globin expression upregulated
more significantly and comparable levels of βH1 and εy
transcripts were observed in CD71high cells after culturing for
two days in vitro (Fig. 3B). This phenomenon mimics the
maturation process of EryPs from YS in vivo (Kingsley et al.,
2006). In addition, when cultured for 3 days with cytokines
including EPO on OP9, a stromal cell line that supports
hematopoietic induction from ESCs (Nakano et al., 1994;
Wang et al., 2005), the pellet from CD71high cells turned red,
an indicator of erythrocyte maturation (Fig. 3C). Similarly,
“maturational globin switching” was detected as well in
A day 4.5 EB BM muscle
C
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Figure 1 CD71high population exists along EB differentiation. (A–B) Flow cytometry analyses of CD71 on EBs, BM, and muscle cells
(A) or on EB cells at various time points during ESC differentiation (B). (C) Staining of CD71 with markers for endothelial cells (CD31
and Flk1), hematopoietic progenitors (CD41), myeloid–lymphoid lineages (CD45), or for maturing erythrocytes (Ter119).
33CD71high as a marker to purify EryPs from differentiated ESCsCD71high cells upon co-culturing with OP9 cells (Supplemen-
tary Fig. S1F).
However, despite that globin switching occurred during
in vitro maturation of CD71high cells, no Ter119+ or
enucleated cells were observed during these processes
(data not shown), indicating an incomplete differentiation
of CD71high cells under this condition. Since Ter119+ cells
were detected in day 8 EBs, we further explored whether
these CD71high cells could mature into Ter119+ or enucle-
ated cells in the niche of EB microenvironment. In this
assay, day 5 wildtype EBs were dissociated and
re-aggregated with sorted GFP+CD71high or GFP+CD71low/
med cells and cultured for four more days. We observed a
higher percentage of Ter119+ cells in GFP+ (9.62%) thanGFP− (3.08%) group derived from the re-aggregated EBs
with GFP+CD71high cells, while comparable formation of
Ter119+ population was seen in those from EBs mixed with
GFP+CD71low/med cells (Fig. 3D). In addition, enucleated
erythrocytes were detected in sorted GFP+Ter119+ cells as
shown by Wright-Giemsa staining (Fig. 3D). Vybrant
DyeCycle™ Ruby is a dye that only stains DNA of live cells,
and thus terminal differentiated erythrocytes without
nuclei will not be stained. We observed that in Ter119+
fraction about 2–3% of cells that were stained negative for
this dye, 5 times more than those detected in Ter119− cells,
indicating an existence of enucleated Ter119+ erythro-
cytes. We further adapted a protocol developed by McGrath
et al. to induce enucleation of EryPs by co-culturing
CD
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Figure 2 CD71high population represents EryPs differentiated from mESCs. (A–C) Real-time RT-PCR on SSEA1-sorted day 5 EB cells,
YS at 8.5 dpc, FL at 14.5 dpc, and CD71+ EryDs from adult BM. (D) Morphology of sorted CD71low/med and CD71high cells. Scale bars:
50 μm. (E–F) Colony forming assay on CD71low/med, CD71high cells from day 5 EBs, and YS isolated at 8.5 dpc. Scale bars: 100 μm.
Panels on the right show images with higher magnification. (G) Morphology of cells collected from erythroblast colonies of YS and
CD71high 5 days post plating. Scale bars: 50 μm.
34 R. Chao et al.CD71high cells with macrophages (McGrath et al., 2008).
We found that the enucleated erythrocytes were increased
to 10% from the Ter119+ population when CD71high
cells were co-cultured with BM-derived macrophages(Fig. 3E). Therefore, our data supported the notion that
putative EryPs from ESC-derived CD71high cells were able to
undergo “maturational globin switching” and enucleation in
vitro.
35CD71high as a marker to purify EryPs from differentiated ESCsFormation of CD71high EryPs is regulated by
transcription factors
The specification and terminal maturation of erythroblasts
are regulated by various signals and transcription factors
(Isern et al., 2011). To explore if CD71high population can beA
C
D
Figure 3 In vitro maturation of CD71high cells. (A) Morphology of C
two days. (B) Real-time RT-PCR analyses of hemoglobin expression
vitro for two days. The relative expression of βH1 to εy-globin in CD7
was shown in lower panel. (C) Pellets from CD71low/med, peripheral b
Flow cytometry analyses of GFP+CD71low/med or GFP+CD71high cells
more days. Wright–Giemsa staining of PBL and sorted Ter119+GFP+ c
co-cultured with BM-derived macrophages analyzed for Ter119 positi
cells was shown on the right. Scale bars: 20 μm.used as a model to evaluate the function of transcription
factors in primitive hematopoiesis, we established several
doxycycline (Dox) inducible ESC lines and explored the
effects of key transcription factors in the formation of
CD71high EryPs during ESC differentiation (Supplemental
Figs. S2A–B). It was previously reported that the lineagesB
E
ε
β
D71low/med and CD71high cells from day 5 EBs growing in vitro for
on day 5 EB-derived CD71high cells and CD71high cells growing in
1high population and CD71high cells growing in vitro for two days
lood (PBL), and CD71high cells growing on OP9 for three days. (D)
which were re-aggregated with wildtype EBs and cultured for 4
ells was shown on the right. Scale bars: 50 μm. (E) CD71high cells
vity and enucleation. Wright–Giemsa staining of sorted Ter119+
36 R. Chao et al.of erythrocytes and megakaryocytes in primitive hemato-
poiesis were generated from bipotential precursors
(Klimchenko et al., 2009; Tober et al., 2007). We found
that ectopic expression of Fli1, Erg, and HoxB4 from day 2 toA
B
D
C
H
F
E
G
I
Figure 4 Formation of CD71high population is regulated different
cytometry analyses of CD71 on day 5 EBs differentiated from Dox-in
(Dox−). (C) Transcript levels of genes in hematopoiesis were measur
ESCs. (D–E) Flow cytometry analyses of CD71 (D) and real-time RT-P
ESCs. (F) Expression of Scl and CD71 in MEL upon Scl knockdown by
wildtype and Scl−/− EBs at day 5 post differentiation. (H–I) real-time
differentiated from ESCs with scrambled shRNA (SCR) or shRNA (KD1day 5 of EB differentiation inhibited the formation of
CD71high EryPs (Fig. 4A, Supplementary Fig. S2F). By
contrast, acting as a key regulator in erythropoiesis, Klf1
overexpression significantly promoted the development ofially by key transcription factors in hematopoiesis. (A–B) Flow
ducible ESCs in the presence (Dox+) or absence of doxycycline
ed by real-time RT-PCR on day 5 EBs from doxycycline inducible
CR (E) on day 5 EBs differentiated from doxycycline inducible Scl
two different shRNAs. (G) Flow cytometry analyses of CD71 on
RT-PCR (H) and flow cytometry analyses of CD71 (I) on day 5 EBs
& KD2) against Eaf1.
37CD71high as a marker to purify EryPs from differentiated ESCsCD71high cells from differentiated EBs (Fig. 4B, Supplemen-
tary Fig. S2F). Consistent with these findings, the transcript
levels of βH1 and εy globins were downregulated in HoxB4
overexpressing cells but upregulated in Klf1-induced day 5
EBs (Fig. 4C). On the contrary, levels of genes specific for
megakaryopoiesis such as PF4 and PPBP were increased upon
HoxB4 induction, but reduced when Klf1 was ectopically
expressed (Fig. 4C). These data thus supported the notion
that primitive megakaryocytes and erythrocytes come from
the same precursor and one may be upregulated at the
expense of another lineage.
Scl plays an important role in erythroid development and
also acts as a master regulator for hematopoiesis (Aplan et al.,
1992; Porcher et al., 1996). When induced by Dox, Scl
significantly upregulated the formation of CD71high EryPs at
different time points along EB differentiation and promoted the
expression of genes in erythroid formation, megakaryopoiesis,
and myeloid development (e.g. PU.1) (Figs. 4D, E, & Supple-
mentary Fig. S2C). Upon Scl knockdown in MEL, an
erythroleukemic cell line, CD71 expression was significantly
downregulated (Fig. 4F). More importantly, although low to
mediate level of CD71 expression was still observed from Scl−/−
EBs, the CD71high population disappeared in Scl null cells
(Fig. 4G). These data thus provide direct evidence that Scl
regulates primitive erythropoiesis.
We further investigate whether newly identified genes in
EryPs play a role in formation of CD71high cells. Although no
obvious changes in percentage of CD71high cells were
observed upon induced expression of Foxh1 or Cited2 by
Dox (Supplementary Figs. S2E–F), depletion of Eaf1 (a gene
that played a role in zebrafish hematopoiesis, Hu et al.,
2014) by RNAi significantly inhibited the formation of
CD71high population and down-regulated expression of βH1
and εy globins (Figs. 4H–I, Supplementary Fig. S2G),
suggesting that Eaf1 is required for derivation of EryPs
from mESCs.Discussion
In vitro differentiation of ESCs closely mimics early embryonic
development and can produce large quantity of hematopoietic
cells. However, segregation of the EryPs from surrounding cells
differentiated from mESCs has not been reported. Here, we
demonstrated that CD71high could be utilized as a marker to
purify EryPs fromdifferentiated ESCs. Although overlappedwith
markers for hematopoietic progenitors, CD41 and c-kit, the
CD71high population was exclusive for myeloid-lymphoid cells
which were positive for CD45. In addition, CD71high cells sorted
from day 5 EBs appeared to be homogenous, highly enriched for
erythroblasts that gave rise about 800 red colonies per 10,000
cells. These data clearly demonstrate that EryPs in the CD71high
population are the dominant blood lineage. As previously
reported, EryPs differ significantly from EryDs in size, globin
expression, and transcriptional regulation (Baron et al., 2012;
Fraser, 2013; Palis et al., 2010). The molecular mechanisms
underlying these differences are however only partially
described because significant amounts of EryPs are required
for such mechanistic investigation. Efficient production and
segregation of CD71high EryPs from differentiated ESCs will
therefore allow us to explore these fundamental questions
during erythropoiesis.Similarly to EryPs from YS around 8.5 dpc, βH1 was the
predominant type of embryonic goblin in CD71high cells. These
putative CD71high EryPs were able to go through “maturational
globin switching” and exhibited similar expression pattern with
YS-derived EryPs. More importantly, we further demonstrated
that these CD71high cells matured into Ter119+ enucleated red
blood cells when co-culturing with macrophages in vitro. These
data thus validate our claim that CD71high population represents
an in vitro counterpart of YS-derived EryPs that can mature and
enucleate. Notably, enucleation of erythrocytes in vitro has
been a challenge in the field of hematopoietic research. It will
be of great interest to explore the specific contribution of
macrophages may have during this process in the future study.
According to current model, bi-potential megakaryocyte-
erythroid precursors (MEPs) exist during primitive hematopoi-
esis (Klimchenko et al., 2009; Tober et al., 2007). However, it
remains unclear how the fate specification of EryPs and
megakaryocytes is regulated. We found that Scl promoted the
formation of all blood lineages from mESCs as a master
regulator of hematopoiesis. In contrast, megakaryopoietic
differentiation depends more stringently on Ets family
members, such as Erg and Fli1. At the expense of megakar-
yocytic development, induction of Klf1 favored the commit-
ment of erythrocytes by upregulating CD71high population and
transcript levels of βH1 and εy globins. Similarly, Eaf1
depletion blocked the development of erythrocytes as
demonstrated by reduced percentage of CD71high cells, thus
indicating a critical requirement of Eaf1 in the formation of
EryPs. Therefore, our approach to utilize CD71high EryPs from
ESCs coupled with genetic modification may represent a
valuable model to examine cell-intrinsic regulation of primi-
tive erythropoiesis during early embryonic development.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.11.002.
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